Elvitegravir can cause changes in the immune system (immune reconstitution inflammatory syndrome [IRIS]). IRIS can be mild or life-threatening.
Elvitegravir must be taken in combination with a protease inhibitor HIV medicine that is co-administered with the HIV medicine ritonavir (brand name: Norvir) and in combination with another HIV medicine.
Do not take elvitegravir if you are taking cobicistat (brand name: Tybost) with a protease inhibitor or if you are taking other medicines that contain elvitegravir (for example, Stribild).
While taking elvitegravir, it is important to keep all of your appointments with your health care provider.
Elvitegravir is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV infection in adults who are already taking or have taken HIV medicines before. Elvitegravir is always used in combination with other HIV medicines.
Elvitegravir belongs to a class (group) of HIV drugs called integrase inhibitors. Integrase inhibitors block an HIV enzyme called integrase. (An enzyme is a protein that starts or increases the speed of a chemical reaction.) By blocking integrase, integrase inhibitors prevent HIV from multiplying and can reduce the amount of HIV in the body. When used with other HIV medicines, elvitegravir may lower the amount of HIV in the blood.
HIV medicines can’t cure HIV/AIDS, but taking a combination of HIV medicines (called an HIV regimen) every day helps people with HIV live longer, healthier lives. HIV medicines also reduce the risk of HIV transmission. If you are taking HIV medicines, including elvitegravir, don’t cut down on, skip, or stop taking them unless your health care provider tells you to.
Before taking elvitegravir, tell your health care provider:
Elvitegravir comes in tablet form in two strengths:
Take elvitegravir according to your health care provider’s instructions.
Take elvitegravir with food. Elvitegravir must be taken in combination with a protease inhibitor HIV medicine that is co-administered with the HIV medicine ritonavir (brand name: Norvir) and in combination with another HIV medicine. Talk to your health care provider about the HIV medicines you are taking.
If you take too much elvitegravir, contact your health care provider or local poison control center (1-800-222-1222) right away, or go to the nearest hospital emergency room.
For more information on how to take elvitegravir, see the FDA drug label from DailyMed. (DailyMed is a federal website that includes the most recent drug labels submitted to FDA.)
If you miss a dose of elvitegravir, take the missed dose as soon as you remember it. But if it is almost time for your next dose, skip the missed dose and just take your next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.
Elvitegravir can cause serious side effects. This includes changes in the immune system (immune reconstitution inflammatory syndrome [IRIS]). IRIS can be mild or life-threatening. (See the WARNING above.)
Other possible side effects of elvitegravir include:
More information about elvitegravir is available:
Gilead Sciences, Inc.
Last Reviewed: October 13, 2014
Last Updated: October 13, 2014